These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Drug receptor interactions. Basis for the action of foreign substances. I]. Kurz H Med Monatsschr Pharm; 1987 May; 10(5):132-8. PubMed ID: 3600489 [No Abstract] [Full Text] [Related]
43. Novel drug treatments for pain in advanced cancer and serious illness: a focus on neuropathic pain and chemotherapy-induced peripheral neuropathy. Davis MP Palliat Care Soc Pract; 2024; 18():26323524241266603. PubMed ID: 39086469 [TBL] [Abstract][Full Text] [Related]
45. α(2) Adrenergic and imidazoline receptor agonists prevent cue-induced cocaine seeking. Smith RJ; Aston-Jones G Biol Psychiatry; 2011 Oct; 70(8):712-719. PubMed ID: 21783176 [TBL] [Abstract][Full Text] [Related]
46. Presynaptic I1-imidazoline receptors reduce GABAergic synaptic transmission in striatal medium spiny neurons. Tanabe M; Kino Y; Honda M; Ono H J Neurosci; 2006 Feb; 26(6):1795-802. PubMed ID: 16467528 [TBL] [Abstract][Full Text] [Related]
47. Induction of reactive astrocytosis and prevention of motoneuron cell death by the I(2)-imidazoline receptor ligand LSL 60101. Casanovas A; Olmos G; Ribera J; Boronat MA; Esquerda JE; García-Sevilla JA Br J Pharmacol; 2000 Aug; 130(8):1767-76. PubMed ID: 10952664 [TBL] [Abstract][Full Text] [Related]
48. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Olmos G; DeGregorio-Rocasolano N; Paz Regalado M; Gasull T; Assumpció Boronat M; Trullas R; Villarroel A; Lerma J; García-Sevilla JA Br J Pharmacol; 1999 Jul; 127(6):1317-26. PubMed ID: 10455281 [TBL] [Abstract][Full Text] [Related]
49. Pharmacological and molecular discrimination of brain I2-imidazoline receptor subtypes. Olmos G; Alemany R; García-Sevilla JA Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec; 354(6):709-16. PubMed ID: 8971730 [TBL] [Abstract][Full Text] [Related]
50. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine. Chan CK; Burke SL; Zhu H; Piletz JE; Head GA Neuroscience; 2005; 132(4):991-1007. PubMed ID: 15857704 [TBL] [Abstract][Full Text] [Related]
51. Identification and characterization of I1 imidazoline receptors: their role in blood pressure regulation. Bousquet P Am J Hypertens; 2000 Jun; 13(6 Pt 2):84S-88S. PubMed ID: 10921526 [TBL] [Abstract][Full Text] [Related]
52. The renaissance of centrally acting antihypertensive drugs. van Zwieten PA J Hypertens Suppl; 1999 Aug; 17(3):S15-21. PubMed ID: 10489094 [TBL] [Abstract][Full Text] [Related]
53. Does a second generation of centrally acting antihypertensive drugs really exist? Feldman J; Greney H; Monassier L; Vonthron C; Bruban V; Dontenwill M; Bousquet P J Auton Nerv Syst; 1998 Oct; 72(2-3):94-7. PubMed ID: 9851557 [TBL] [Abstract][Full Text] [Related]
54. Imidazoline receptors: from basic concepts to recent developments. Bousquet P J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S1-6. PubMed ID: 8642798 [TBL] [Abstract][Full Text] [Related]